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Abstract
We studied 25 patients with proximal myotonic myopathy (PROMM) from 3 unrelated
kindreds and present data on the clinical spectrum of this syndrome. Our data show that
phenotypic expression and degree of multisystem involvement may vary widely between and
within kindreds. In conclusion our results suggest clinical and genetic heterogeneity of
PROMM syndromes.
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The first reports on proximal myotonic myopathy
(PROMM) families [8, 9, 14, 15, 19, 20] defined the
clinical and genetic data in this syndrome. The diagnosis
was based on the finding of autosomal dominant transmis-
sion of proximal muscle weakness, myotonia and cataracts
in the presence of a normal size CTG expansion on chro-
mosome 19 [2, 3, 4, 5]. The initial reports were all consis-
tent with this clinical picture. From a clinical point of view,
autosomal dominant inheritance was always present, onset
of symptoms was usually in the 30s or 40s, and no infantile
or childhood cases had been described. There was no report
of congenital cases of PROMM similar to the severe form
described in myotonic dystrophy from affected mothers.
The most frequent symptom at onset in the patients with
PROMM described was myotonia, often painful and caus-
ing stiffness in the hands. A warm-up phenomenon was
described in many patients. All patients described had
myotonic discharges on EMG. However, it was unclear
from the initial reports, that myotonic discharges could be
very difficult to find, especially when symptoms of myo-
tonia or muscle weakness were not very prominent, like in
at risk individuals from affected parents. The initial reports
were also very focused on the proximal distribution of
muscle weakness in muscles of normal bulk, compared to
the distal atrophy and weakness described in patients with
myotonic dystrophy (DM) [7], to the extent that the disor-
der was termed proximal myotonic myopathy [14, 15].
Hypertrophy of the calves was described in some patients
and tendon reflexes were normal in all patients examined
(even though severely affected) in contrast to the dimin-
ished or absent reflexes in patients with DM. The clinical
picture of PROMM initially appeared quite distinct from
that of patients with DM.
From a genetic point of view, all patients with PROMM
had normal size CTG expansion and linkage to chromo-
mose 19, 7 and 17 was excluded in 4 large unrelated
kindreds with PROMM [8, 14, 15], suggesting genetic
homogeneity and again underlying that PROMM was a
disorder similar to, but distinct from DM.
The increasing number of reports that followed underly-
ing the multisystem involvement and the variability in
clinical expression [12], made it clear that the clinical
picture of PROMM was not as homogeneous as initially
thought, and that PROMM should be considered a syn-
drome, maybe controlled by multiple and distinct genes
from DM. Abruzzese et al. [1] described 3 families with
DM phenotype in whom affected individuals within a same
family had a normal or abnormal degree of CTG expan-
sion.
It is now clear that careful clinical evaluation of patients
with PROMM often reveals that the actual similarities of
the signs and symptoms to those in DM are only limited
and not exact. Although the distribution of weakness is
definitely proximal rather than distal in PROMM and
myotonia is present, the clinical manifestations of the
disease vary widely. Weakness may be hard to detect and
often there may be no underlying muscle wasting [10].
Patients often describe myotonia in a very specific and
reproducible manner describing 'locking' of the hands,
reduced finger dexterity as in arthritis, stiffness or pain.
However, these symptoms may be intermittent and totally
absent on clinical testing with no evidence of percussion
or grip myotonia. Similarly, electromyography findings
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may not reveal any myotonic discharges even after cool-
ing. Cataracts are not easily detectable on ophthal-
moscopic examination and a slit-lamp test is often required
to rule out the typical lens opacities found in DM. The
diagnosis of at-risk individuals is therefore difficult to
establish. This has obvious genetic implications for link-
age studies. Given the clinical variability and the apparent
low penetrance of the disease, caution is therefore neces-
sary in defining affected individuals, especially because
the natural history of PROMM is still being determined.
Moreover, the expressivity of the disease varies widely and
no specific early diagnostic test for PROMM has yet been
described.
Materials and Methods
PROMM - the clinical picture
We describe the clinical spectrum of this disorder based
on our experience in 25 individuals from 3 unrelated
PROMM families.
The pattern of muscle involvement (Table 1)
Facial weakness
Facial weakness, one of the earliest and most constant
features of DM, was not a prominent feature of our pa-
tients, although mild facial asymmetries were noticed
when the patients smiled or talked. The typical expression-
less face resulting from weakness of the facial muscles,
and from weakness and wasting of the jaw muscles in
patients with typical DM was not a feature of our PROMM
patients, independent of age and duration of disease.
Ptosis
Ptosis, generally symmetrical and an integral part of the
facies in patients with DM was absent in our patients with
PROMM, although fluctuations in myotonia in the orbicu-
laris oculi sometimes gave the impression of a variable and
fluctuating degree of opening of the eyes.
Extraocular muscles
Formal testing and symptoms attributable to extraocular
muscle weakness were absent in our patients.
Jaw muscles
Wasting of the temporalis muscles is a prominent feature
of myotonic dystrophy, but was absent in our patients with
PROMM. However, temporo-mandibular dislocation,
well-documented in DM, was also a feature of our patients.
Recurrent locking of the jaw, difficulty in chewing and
frequent clicks were the main complaints.
Palate and tongue
Weakness of the palate contributes to the nasal, indistinct
speech that may trouble adults with advanced features of
DM, but was not a feature of PROMM, even in advanced
cases. None of our patients complained of difficulty swal-
lowing and had a narrow, high-arched palate.
Sternomastoids
Inability to raise the head while in bed was a complaint
in some patients and many patients were unable to raise
their heads against gravity while supine. This occurred at
a stage when the involvement of most other muscles was
relatively mild.
Limb weakness
The onset of muscle weakness was proximal in all of our
patients, although often mild and uncomplained of by
some patients. Difficulty getting up from a squat or climb-
ing up stairs was often explained on the basis of 'getting
older' or 'out of exercise', especially in relatives of af-
fected individuals. In more advanced cases weakness was
present in the distal muscles also, independent of the
degree of myotonia. Degree of weakness was not corre-
lated to degree of atrophy and weak muscles were usually
of normal bulk, in contrast to the findings in other recently
described PROMM patients [21]. Pseudohypertrophy of
the calves was occasionally seen in some patients. Degree
of muscle involvement varied between patients and 4 of
our patients were wheel-chair bound, irrespective of age
and disease duration. Tendon reflexes were preserved in
all patients, even in muscles with severe involvement.
Myotonia
This phenomenon, the hallmark of DM, can be elicited
in patients with PROMM but is not as constant and repro-
ducible, especially in presymptomatic individuals, as it is
in DM. It is the most frequent symptom at onset in our
patients with PROMM. Patients often complain of stiff-
ness, usually painful, but variable, and precipitated by
changes in temperature, both high and low. Repeated
exercise of the hands, releaves the pain and stiffness lo-
cally. Myotonia, best tested in the hand muscles where,
following a forceful grip, there is a delayed ability to relax
the grip, might be present on examination one day and
absent the following day. Even less constant and difficult
to find is myotonia on percussion of the thenar muscles. In
contrast to patients with DM, patients with PROMM com-
plain of the phenomenon, especially when painful and
sometimes interpret it as arthritis. Percussion myotonia in
the tongue was a more constant and reproducible feature
than grip myotonia. All patients with definite clinical
myotonia had myotonic discharges on EMG. However,
when symptoms of stiffness and pain in the hands or legs
were present, myotonic discharges were difficult to elicit
and when present, were often short-lasting, and varied
from day to day in the same patient. In a few cases, heating
the muscles or performing a long-lasting exercise test [16,
17], precipitated the myotonic discharges. In other pa-
tients, no definite myotonic discharges were present, yet
there were fibrillation potentials in the muscles examined.
These findings are currently being investigated. All our
patients show a good therapeutic response to mexiletine,
at a dosage of 200mg bid.
Systemic aspects (Table 2)
The occurrence of a variety of abnormalities outside
muscle is perhaps the most characteristic emerging feature
of PROMM, and these abnormalities are both a help in
diagnosis and also a problem when they are the presenting
feature rather than an accompanying one. The systemic
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Table 1. Muscle involvement. Table 2. Systemic involvement.
FACIAL
PTOSIS
EXTRAOCULAR
JAW MUSCLES
PALATE, TONGUE
STERNOMASTOIDS
LIMBS
lower limbs
upper limbs
proximal muscles
flexors
extensors
difficulties are also of major importance in management
and prognosis, and in many patients in our experience are
of considerably greater importance than the muscular as-
pects.
a) Smooth muscle
From our experience patients with PROMM may com-
plain of difficulties urinating, experiencing cramps and
painful contractions during micturition, apparently not
justified by tests of the urinary tract. Other patients com-
plain of difficulties with digestion, describing it as slow,
often painful in the absence of signs of gastrointestinal
structural involvement.
b) Heart
None of our patients presented with conduction abnor-
malities and none required a pacemaker. Blood pressure
and other signs of vascular abnormalities were absent.
c) Peripheral nerve
Many patients experienced a decreased sense of vibra-
tion but rarely this was clinically significant.
d) Brain
We studied 10 patients with PROMM with MRI or CT
scans and no structural abnormality was found. In some
there was an increase in thecal thickness similar to findings
in DM. Neuropsychological tests showed impairment in
visuospatial functions in all PROMM patients independent
of degree of muscle involvement [18].
e) Endocrine
Many of our patients complained of infertility and go-
nadotrophins were reduced in some patients* in association
with gonadal atrophy. The significance of these findings is
to be determined. Diabetes was not a feature of our pa-
tients. However, oral and intravenous glucose challenges
showed elevated levels of insulin at rest. There was post-
prandial hyperinsulinemia in many of our PROMM pa-
tients suggesting features of insulin-resistance similar to
those found in DM [11, 13].
f) Eye
Iridescent cataracts, identical to those found in DM were
present in all our definitely affected patients with
SMOOTH MUSCLE
CARDIAC MUSCLE
PERIPHERAL NERVE
BRAIN
CATARACTS
SKELETAL
SKIN
INFERTILITY
DIABETES
PROMM. We were unable to use this test to screen for
patients with mild symptoms in whom the diagnosis of
PROMM was uncertain because the abnormalities found
on slit-lamp examination were indistiguishable from those
found in the general population.
g) Skeleton
Thickening of the skull was found in many of our patients
tested on X-ray or CT scans, but the significance of this is
to be determined.
h) Skin
In some of our patients easy blistering, skin allergies and
bruises were a common complaint. However there was no
evidence of these symptoms being present only in patients
with muscle complaints and it was not possible to identify
this as a constant feature of these patients.
Diagnostic work-up
Careful clinical assessment, laboratory tests and genetic
analysis will allow to recognize predictive tests of proven
value in PROMM and tests of limited or uncertain value.
Clinical assessment is by far the most important single
measure. No relative should be considered unaffected un-
less a careful search has been made for myotonia and
muscle weakness. Electromyography should always be
done in at-risk individuals, should be performed after
cooling and heating of the muscle and should be repeated
at several points in time in different muscles before it is
considered negative. Slit-lamp examination is extremely
valuable, especially in the elderly to distinguish specific
opacities from those changes commonly seen in the eld-
erly. It is not uncommon for nonspecific whitish opacities
to be the only finding in at-risk individuals. It is wise to
regard this finding as equivocal and to repeat the test in 1
or 2 years. Molecular analysis is mandatory to rule out
linkage to the DM gene on chromosome 19. Other predic-
tive tests have limited or uncertain value like CK determi-
nation. Definitely affected individuals have been seen with
normal CK. The same applies for gamma-GT elevation.
Serum FSH, LH and testosterone and insulin response to
oral or intravenous glucose are still of uncertain value.
Muscle biopsy is of limited value in PROMM. It is impor-
tant to rule out myotonia congenita on the basis of the
presence of type IIB fibres on muscle biopsies of PROMM
patients. However, mild to moderate increase in central
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nuclei, some scattered angulated and atrophic fibers in the
absence of chronic signs of denervation (i.e. type-group-
ing), have been found in the majority of PROMM patients.
In a few patients several central nuclei, type I fiber atrophy
and type II fiber hypertrophy, ring-binden fibers have been
seen [6] like in DM.
Conclusions
Natural history
There is no data on the natural history of the disease yet.
However, from our experience and from the literature data,
the clinical variability is significant, varying from milder
cases only with muscle pain to wheel-chair bound patients.
Moreover, since some minor aspects of multisystem
involvement are still to be defined, it is difficult to under-
stand whether some features present in at risk individuals
(eg infertility, thyroid dysfunction, cognitive abnormali-
ties, etc,) are to be considered as a clinical manifestation
of the disease or whether certain abnormalities occur by
chance in these individuals and with no statistical differ-
ence from the general population. From our 4-year follow-
up experience in one large kindred progression of
weakness occurs slowly but varies from patient to patient.
In particular one 37-year-old patient became wheel-chair
bound within 2 years from our diagnosis. In retrospect,
onset of symptoms had been around age 13 with myotonic
complaints.
Age of onset
PROMM had initially been described as a late-onset
myopathy. As more and more patients are being described,
onset varies from 10 years of age [14, 15] to 60 years of
age. In our experience onset of symptoms was in general
in the 30s or 40s but many patients experienced stiffness
and pain since their young adulthood. If disorders of men-
strual cycle, thyroid dysfunction or other abnormalities
will be included as possible manifestations of PROMM,
age of onset may vary further.
Prognosis
In general, because of the less frequent involvement of
cardiac and respiratory muscles, patients with PROMM
have been considered to have a better prognosis compared
to patients with DM. Moreover, no congenital form of
PROMM has yet been described and although central
nervous system involvement has been suggested as a fea-
ture of PROMM, this is a possible but unusual presentation
of the syndrome. In our experience, the cardiac conduction
system is spared and none of our patients required a pace-
maker or cardiac treatment. Similarly none complained of
respiratory distress or sleep apnea. However, natural his-
tory data are lacking and although apparently a better one,
caution is necessary before prognostic factors are consid-
ered.
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